US Stock MarketDetailed Quotes

VistaGen Therapeutics (VTGN)

Watchlist
  • 0.6000
  • +0.0240+4.17%
Close Apr 14 16:00 ET
  • 0.6300
  • +0.0300+5.00%
Post 20:01 ET
23.77MMarket Cap-0.32P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

VistaGen Therapeutics (VTGN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Total revenue
29.49%303K
40.98%258K
190.48%244K
-54.32%486K
-107.61%-15K
-43.07%234K
-34.17%183K
-52.54%84K
568.72%1.06M
12.00%197K
Operating revenue
29.49%303K
40.98%258K
190.48%244K
-54.32%486K
-107.61%-15K
-43.07%234K
-34.17%183K
-52.54%84K
568.72%1.06M
12.00%197K
Cost of revenue
Gross profit
Operating expense
29.28%19.85M
40.95%20.31M
31.38%16.05M
65.64%56.46M
25.30%14.48M
85.10%15.35M
104.17%14.41M
70.24%12.22M
-42.27%34.09M
-6.92%11.56M
Selling and administrative expenses
38.95%5.63M
4.79%4.4M
-4.31%4.37M
21.48%17.08M
3.71%4.27M
7.74%4.05M
30.81%4.2M
53.36%4.57M
-4.10%14.06M
33.85%4.12M
-General and administrative expense
38.95%5.63M
4.79%4.4M
-4.31%4.37M
21.48%17.08M
3.71%4.27M
7.74%4.05M
30.81%4.2M
53.36%4.57M
-4.10%14.06M
33.85%4.12M
Research and development costs
25.81%14.22M
55.80%15.92M
52.69%11.68M
96.66%39.38M
37.26%10.21M
149.17%11.31M
165.26%10.22M
82.23%7.65M
-54.88%20.02M
-20.36%7.44M
Operating profit
-29.27%-19.55M
-40.95%-20.05M
-30.28%-15.8M
-69.51%-55.97M
-27.61%-14.5M
-91.78%-15.12M
-109.84%-14.23M
-73.35%-12.13M
44.29%-33.02M
7.19%-11.36M
Net non-operating interest income expense
-37.25%647K
-50.51%630K
-49.14%711K
35.99%4.56M
-44.01%855K
-32.79%1.03M
563.02%1.27M
1,326.53%1.4M
12,788.46%3.35M
12,314.63%1.53M
Non-operating interest income
-37.25%647K
-50.51%630K
-49.14%711K
35.99%4.56M
-44.01%855K
-32.79%1.03M
563.02%1.27M
1,326.53%1.4M
--3.35M
--1.53M
Total other finance cost
----
----
----
----
----
----
----
----
-12,788.46%-3.35M
----
Other net income (expense)
6K
-2K
-98.40%5K
312K
Other non- operating income (expenses)
----
--6K
---2K
-98.40%5K
----
----
----
----
--312K
----
Income before tax
-34.14%-18.9M
-49.89%-19.42M
-40.64%-15.1M
-75.12%-51.41M
-43.22%-13.64M
-121.87%-14.09M
-96.63%-12.95M
-55.55%-10.73M
50.44%-29.36M
22.14%-9.52M
Income tax
0
0
0
75.00%7K
0
0
7K
0
-33.33%4K
100.00%1K
Net income
-34.14%-18.9M
-49.81%-19.42M
-40.64%-15.1M
-75.12%-51.42M
-43.21%-13.64M
-121.87%-14.09M
-96.74%-12.96M
-55.48%-10.73M
50.44%-29.36M
22.13%-9.52M
Net income continuous Operations
-34.14%-18.9M
-49.81%-19.42M
-40.64%-15.1M
-75.12%-51.42M
-43.21%-13.64M
-121.87%-14.09M
-96.74%-12.96M
-55.48%-10.73M
50.44%-29.36M
22.13%-9.52M
Minority interest income
Net income attributable to the parent company
-34.14%-18.9M
-49.81%-19.42M
-40.64%-15.1M
-75.12%-51.42M
-43.21%-13.64M
-121.87%-14.09M
-96.74%-12.96M
-55.48%-10.73M
50.44%-29.36M
22.13%-9.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-34.14%-18.9M
-49.81%-19.42M
-40.64%-15.1M
-75.12%-51.42M
-43.21%-13.64M
-121.87%-14.09M
-96.74%-12.96M
-55.48%-10.73M
50.44%-29.36M
22.13%-9.52M
Basic earnings per share
2.17%-0.45
-28.57%-0.54
-34.29%-0.47
-9.87%-1.67
-24.89%-0.44
-109.09%-0.46
36.36%-0.42
62.77%-0.35
82.14%-1.52
79.15%-0.3523
Diluted earnings per share
2.17%-0.45
-28.57%-0.54
-34.29%-0.47
-9.87%-1.67
-24.89%-0.44
-109.09%-0.46
36.36%-0.42
62.77%-0.35
82.14%-1.52
79.15%-0.3523
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Total revenue 29.49%303K40.98%258K190.48%244K-54.32%486K-107.61%-15K-43.07%234K-34.17%183K-52.54%84K568.72%1.06M12.00%197K
Operating revenue 29.49%303K40.98%258K190.48%244K-54.32%486K-107.61%-15K-43.07%234K-34.17%183K-52.54%84K568.72%1.06M12.00%197K
Cost of revenue
Gross profit
Operating expense 29.28%19.85M40.95%20.31M31.38%16.05M65.64%56.46M25.30%14.48M85.10%15.35M104.17%14.41M70.24%12.22M-42.27%34.09M-6.92%11.56M
Selling and administrative expenses 38.95%5.63M4.79%4.4M-4.31%4.37M21.48%17.08M3.71%4.27M7.74%4.05M30.81%4.2M53.36%4.57M-4.10%14.06M33.85%4.12M
-General and administrative expense 38.95%5.63M4.79%4.4M-4.31%4.37M21.48%17.08M3.71%4.27M7.74%4.05M30.81%4.2M53.36%4.57M-4.10%14.06M33.85%4.12M
Research and development costs 25.81%14.22M55.80%15.92M52.69%11.68M96.66%39.38M37.26%10.21M149.17%11.31M165.26%10.22M82.23%7.65M-54.88%20.02M-20.36%7.44M
Operating profit -29.27%-19.55M-40.95%-20.05M-30.28%-15.8M-69.51%-55.97M-27.61%-14.5M-91.78%-15.12M-109.84%-14.23M-73.35%-12.13M44.29%-33.02M7.19%-11.36M
Net non-operating interest income expense -37.25%647K-50.51%630K-49.14%711K35.99%4.56M-44.01%855K-32.79%1.03M563.02%1.27M1,326.53%1.4M12,788.46%3.35M12,314.63%1.53M
Non-operating interest income -37.25%647K-50.51%630K-49.14%711K35.99%4.56M-44.01%855K-32.79%1.03M563.02%1.27M1,326.53%1.4M--3.35M--1.53M
Total other finance cost ---------------------------------12,788.46%-3.35M----
Other net income (expense) 6K-2K-98.40%5K312K
Other non- operating income (expenses) ------6K---2K-98.40%5K------------------312K----
Income before tax -34.14%-18.9M-49.89%-19.42M-40.64%-15.1M-75.12%-51.41M-43.22%-13.64M-121.87%-14.09M-96.63%-12.95M-55.55%-10.73M50.44%-29.36M22.14%-9.52M
Income tax 00075.00%7K007K0-33.33%4K100.00%1K
Net income -34.14%-18.9M-49.81%-19.42M-40.64%-15.1M-75.12%-51.42M-43.21%-13.64M-121.87%-14.09M-96.74%-12.96M-55.48%-10.73M50.44%-29.36M22.13%-9.52M
Net income continuous Operations -34.14%-18.9M-49.81%-19.42M-40.64%-15.1M-75.12%-51.42M-43.21%-13.64M-121.87%-14.09M-96.74%-12.96M-55.48%-10.73M50.44%-29.36M22.13%-9.52M
Minority interest income
Net income attributable to the parent company -34.14%-18.9M-49.81%-19.42M-40.64%-15.1M-75.12%-51.42M-43.21%-13.64M-121.87%-14.09M-96.74%-12.96M-55.48%-10.73M50.44%-29.36M22.13%-9.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -34.14%-18.9M-49.81%-19.42M-40.64%-15.1M-75.12%-51.42M-43.21%-13.64M-121.87%-14.09M-96.74%-12.96M-55.48%-10.73M50.44%-29.36M22.13%-9.52M
Basic earnings per share 2.17%-0.45-28.57%-0.54-34.29%-0.47-9.87%-1.67-24.89%-0.44-109.09%-0.4636.36%-0.4262.77%-0.3582.14%-1.5279.15%-0.3523
Diluted earnings per share 2.17%-0.45-28.57%-0.54-34.29%-0.47-9.87%-1.67-24.89%-0.44-109.09%-0.4636.36%-0.4262.77%-0.3582.14%-1.5279.15%-0.3523
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -